Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 283-042-4 | CAS number: 84539-54-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- 2000-08-10 to 2000-09-11
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 001
- Report date:
- 2001
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: EC Directive No. 96/54/EEC, B.6, 30 July 1996
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- The study was conducted prior to the adoption of OECD 429 for LLNA.
Test material
- Test material form:
- solid: particulate/powder
- Remarks:
- migrated information: powder
- Details on test material:
- - Name of test material (as cited in study report): EDDHAS Fe, sel de K
- Molecular formula (if other than submission substance): C18H14FeN2O12S2(3K)
- Molecular weight (if other than submission substance): 687.3
- Smiles notation (if other than submission substance): O=C(O)C(NCCNC(C(=O)O)c1cc(ccc1(O))S(=O)(=O)O)c2cc(ccc2(O))S(=O)(=O)O
- InChl (if other than submission substance): InChI=1S/C18H20N2O12S2/c21-13-3-1-9(33(27,28)29)7-11(13)15(17(23)24)19-5-6-20-16(18(25)26)12-8-10(34(30,31)32)2-4-14(12)22/h1-4,7-8,15-16,19-22H,5-6H2,(H,23,24)(H,25,26)(H,27,28,29)(H,30,31,32)
- Substance type: Fe chelate
- Physical state: brownish/red powder
- Analytical purity: 55±2%
- Impurities (identity and concentrations): none
- Purity test date: 2000-10-24
- Expiration date of the lot/batch: 2001-01-24
- Stability under test conditions: at least 6 months from receipt (date of receipt: 24 July 2000)
- Storage condition of test material: at room temperature and protected from humidity
- Other:
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Hartley
- Sex:
- male/female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Charles River France, 76410 Saint-Aubin-les-Elbeuf, France
- Age at study initiation: 1-3 months
- Weight at study initiation: 375 ± 24 g for the males and 368 ± 17 g for the females
- Housing: individually in polycarbonate cages (48 cm x 27 cm x 20 cm) equipped with a polypropylene bottle
- Diet (e.g. ad libitum): ad libitum ("106 pelleted diet" (UAR, 91360 Villemoisson-sur-Orge, France))
- Water (e.g. ad libitum): ad libitum (filtered by a FG Millipore membrane (0.22 micron))
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21 ± 2
- Humidity (%): 30 to 70
- Air changes (per hr): approximately 12 cycles/hour of filtered, non-recycled air
- Photoperiod (hrs dark / hrs light): 12 h/12 h
IN-LIFE DATES: From: To:
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal and epicutaneous
- Vehicle:
- physiological saline
- Remarks:
- 0.9% NaCl, batch No. 2831 (Laboratoire Frésénius, 92316 Sèvres, France)
- Concentration / amount:
- Preliminary test:
- By intradermal route (tested concentrations: 50%, 25% and 10% (w/w));
- By cutaneous route (tested concentrations: 50%, 25%, 10% and 5% (w/w)).
Main test:
Induction phase:
- By intradermal route: 10% (w/w);
- By cutaneous route: 10% (w/w).
Challenge phase:
- 5% and 50% (w/w)
Challengeopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- physiological saline
- Remarks:
- 0.9% NaCl, batch No. 2831 (Laboratoire Frésénius, 92316 Sèvres, France)
- Concentration / amount:
- Preliminary test:
- By intradermal route (tested concentrations: 50%, 25% and 10% (w/w));
- By cutaneous route (tested concentrations: 50%, 25%, 10% and 5% (w/w)).
Main test:
Induction phase:
- By intradermal route: 10% (w/w);
- By cutaneous route: 10% (w/w).
Challenge phase:
- 5% and 50% (w/w)
- No. of animals per dose:
- - two males and two females for the preliminary test;
- 30 animals (15 males and 15 females) for the main test: a control group of ten animals (five males and five females) and a treated group of 20 animals (ten males and ten females). - Details on study design:
- RANGE FINDING TESTS:
A preliminary test was conducted in order to determine the concentrations to be tested in the main study.
By intradermal route:
- 24 hours before treatment, the dorsal region of the animals was clipped,
- intradermal administrations of the dosage form preparations (0.1 mL) were performed in the interscapular region,
- cutaneous reactions were evaluated approximately 24, 48 hours and 6 days after the injections.
By cutaneous route:
- 24 hours before treatment, both flank regions of the animals were clipped,
- the filter paper of a chamber (Finn Chamber ) was fully-loaded with the dosage form preparations. The chamber was then applied to the clipped area of the skin (one concentration per flank). The chamber was held in place by means of an occlusive dressing for 24 hours,
- cutaneous reactions were evaluated approximately 24 and 48 hours after removal of the dressings.
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 2 (on day 1: intradermally; on day 8: epicutaneous)
- Test groups:
Intradermal injections (day 1): six injections (0.1 mL) were made (three pairs) into the left and right side of a 4 cm x 2 cm clipped interscapular area:
1) 50% Freund's complete adjuvant (v/v) and sterile isotonic solution (0.9% NaCl);
2) test substance at 10% (w/w) in 0.9% NaCl;
3) test substance at 10% (w/w) in a mixture of FCA/0.9% NaCl (50/50);
Cutaneous application (day 7): 0.5 mL of sodium lauryl sulfate at 10% (w/w) in vaseline in order to induce local irritation;
Cutaneous application (day 8): test substance at 10% (w/w) in 0.9% NaCl
- Control group:
Intradermal injections (day 1): six injections (0.1 mL) were made (three pairs) into the left and right side of a 4 cm x 2 cm clipped interscapular area:
1) 50% Freund's complete adjuvant (v/v) and sterile isotonic solution (0.9% NaCl);
2) 0.9% NaCl;
3) 0.9% NaCl (w/v) in a mixture of FCA/0.9% NaCl (50/50);
Cutaneous application (day 7): 0.5 mL of sodium lauryl sulfate at 10% (w/w) in vaseline in order to induce local irritation;
Cutaneous application (day 8): 0.9% NaCl
By cutaneous application (day 8), a pad of filter paper (approximately 8 cm²) was fully-loaded with the test substance or vehicle alone and then applied to the interscapular region of animals. The pad was held in place for 48 hours by means of an adhesive hypoallergenic dressing and an adhesive anallergenic waterproof plaster).
B. CHALLENGE EXPOSURE
- No. of exposures: 1
- Day(s) of challenge: day 22
- Exposure period: 24 h occlusively
- Test groups: left flank: test substance at 5%; right flank: test substance at 50%
- Control group: left flank: test substance at 5%; right flank: test substance at 50%
- Site: posterior left and right flanks
- Concentrations: 5% and 50% (w/w)
- Evaluation (hr after challenge): 48 hours
OTHER: - Challenge controls:
- On day 22, the animals of treated and control groups received an application of the test substance and vehicle. The filter paper of a chamber (Finn Chamber®) was fully-loaded with the test substance at concentrations of 5% and 50% (w/w) and was then applied to a clipped area of the skin of the posterior left and right flanks of all animals, respectively.
The chambers were held in contact with the skin for 24 hours by means of an adhesive anallergenic waterproof plaster. - Positive control substance(s):
- yes
- Remarks:
- mercaptobenzothiazole
Results and discussion
- Positive control results:
- One control group of 5 animals and one treated group of 10 animals received the positive control substance at the concentration of 1% (w/w) intradermally on day 1; 20% (w/w) was applied cutaneously on day 8
On day 22, MERCAPTOBENZOTHIAZOLE at the concentration of 20% (w/w) induced positive skin sensitization reactions in 70% guinea-pigs (CIT/Study No. 20068 TSG - July 2000).
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 5%
- No. with + reactions:
- 10
- Total no. in group:
- 10
- Clinical observations:
- brown coloration of the skin which could have masked a possible moderate erythema
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: 1st reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 5%. No with. + reactions: 10.0. Total no. in groups: 10.0. Clinical observations: brown coloration of the skin which could have masked a possible moderate erythema.
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 50%
- No. with + reactions:
- 10
- Total no. in group:
- 10
- Clinical observations:
- brown coloration of the skin which could have masked a possible moderate erythema: 7 animals; a possible intense erythema: 3 animals
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: 1st reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 50%. No with. + reactions: 10.0. Total no. in groups: 10.0. Clinical observations: brown coloration of the skin which could have masked a possible moderate erythema: 7 animals; a possible intense erythema: 3 animals.
- Reading:
- 2nd reading
- Hours after challenge:
- 72
- Group:
- negative control
- Dose level:
- 5%
- No. with + reactions:
- 9
- Total no. in group:
- 10
- Clinical observations:
- no coloration of the skin: 1 animal; no coloration/or brown coloration of the skin: 5 animals; brown coloration of the skin which could have masked a possible discrete erythema: 4 animals
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: 2nd reading. . Hours after challenge: 72.0. Group: negative control. Dose level: 5%. No with. + reactions: 9.0. Total no. in groups: 10.0. Clinical observations: no coloration of the skin: 1 animal; no coloration/or brown coloration of the skin: 5 animals; brown coloration of the skin which could have masked a possible discrete erythema: 4 animals.
- Reading:
- 2nd reading
- Hours after challenge:
- 72
- Group:
- negative control
- Dose level:
- 50%
- No. with + reactions:
- 10
- Total no. in group:
- 10
- Clinical observations:
- brown coloration of the skin: 1 animal; brown coloration of the skin which could have masked a possible discrete erythema: 2 animals; a possible moderate erythema: 6 animals; a possible intense erythema: 1 animal
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: 2nd reading. . Hours after challenge: 72.0. Group: negative control. Dose level: 50%. No with. + reactions: 10.0. Total no. in groups: 10.0. Clinical observations: brown coloration of the skin: 1 animal; brown coloration of the skin which could have masked a possible discrete erythema: 2 animals; a possible moderate erythema: 6 animals; a possible intense erythema: 1 animal.
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 5%
- No. with + reactions:
- 20
- Total no. in group:
- 20
- Clinical observations:
- brown coloration of the skin which could have masked a possible moderate erythema: 18 animals; a possible intense erythema: 2 animals
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 5%. No with. + reactions: 20.0. Total no. in groups: 20.0. Clinical observations: brown coloration of the skin which could have masked a possible moderate erythema: 18 animals; a possible intense erythema: 2 animals.
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 50%
- No. with + reactions:
- 20
- Total no. in group:
- 20
- Clinical observations:
- brown coloration of the skin which could have masked a possible moderate erythema: 13 animals; a possible intense erythema: 7 animals
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 50%. No with. + reactions: 20.0. Total no. in groups: 20.0. Clinical observations: brown coloration of the skin which could have masked a possible moderate erythema: 13 animals; a possible intense erythema: 7 animals.
- Reading:
- 2nd reading
- Hours after challenge:
- 72
- Group:
- test chemical
- Dose level:
- 5%
- No. with + reactions:
- 16
- Total no. in group:
- 20
- Clinical observations:
- no coloration of the skin: 4 animals; no coloration/or brown coloration of the skin: 5 animals; brown coloration of the skin which could have masked a possible discrete erythema: 8 animals; a possible moderate erythema: 3 animals
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: 2nd reading. . Hours after challenge: 72.0. Group: test group. Dose level: 5%. No with. + reactions: 16.0. Total no. in groups: 20.0. Clinical observations: no coloration of the skin: 4 animals; no coloration/or brown coloration of the skin: 5 animals; brown coloration of the skin which could have masked a possible discrete erythema: 8 animals; a possible moderate erythema: 3 animals.
- Reading:
- 2nd reading
- Hours after challenge:
- 72
- Group:
- test chemical
- Dose level:
- 50%
- No. with + reactions:
- 20
- Total no. in group:
- 20
- Clinical observations:
- no/or brown coloration of the skin: 2 animals; brown coloration of the skin which could have masked a possible discrete erythema: 3 animals; a possible moderate erythema: 15 animals
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: 2nd reading. . Hours after challenge: 72.0. Group: test group. Dose level: 50%. No with. + reactions: 20.0. Total no. in groups: 20.0. Clinical observations: no/or brown coloration of the skin: 2 animals; brown coloration of the skin which could have masked a possible discrete erythema: 3 animals; a possible moderate erythema: 15 animals.
Any other information on results incl. tables
No clinical signs and no deaths were observed during the study. The body weight gain of the treated animals was similar to that of the control animals.
Challenge phase - Scoring of cutaneous reactions
On the left flank receiving the test substance at the concentration of 5%
A brown coloration of the skin, which could have masked a possible moderate or intense erythema (grade 2 or 3), was observed at the 24-hour reading in all animals of the control and treated groups. At the 48-hour reading, a brown coloration of the skin, which could have masked a possible discrete or moderate erythema (grade 1 or 2), persisted in 4/10 animals of the control group and in 11/20 animals of the treated group; dryness of the skin was also recorded in 1/20 animals of the treated group. No cutaneous reactions were observed in the other animals of both groups.
On the right flank receiving the test substance at the concentration of 50%
A brown coloration of the skin, which could have masked a possible moderate or intense erythema (grade 2 or 3), was observed at the 24-hour reading in all animals of the control and treated groups. At the 48-hour reading, no cutaneous reactions were observed in 1/10 animals of the control group and in 2/20 animals of the treated group. A brown coloration of the skin, which could have masked a possible discrete to intense erythema (grades 1 to 3), persisted in 9/10 animals of the control group and in 18/20 animals of the treated group.
Microscopic examination
Control group: right flank receiving the test substance at the concentration of 50%
Four out of five control males and all the control females showed minimal to moderate acanthosis in the right flank. This was associated in all of them with slight inflammatory cell infiltration of dermis (mainly mononuclear cells) and in some of them with minimal hyperkeratosis, minimal intercellular edema in epidermis, minimal mononuclear cell infiltration in epidermis and/or hair follicle(s) and /or minimal extravasation of red blood cells in the dermis. All these findings were considered to be due to skin irritation.
Treated group: right flank receiving the test substance at the concentration of 50%
Minimal to moderate acanthosis, together with slight inflammatory cell infiltration in the dermis (mainly mononuclear cells), were observed in all the treated males and females. For some of them, minimal hyperkeratosis, minimal intercellular edema in epidermis, minimal mononuclear cell infiltration in epidermis and/or hair follicle(s), minimal extravasation of red blood cells in the dermis and/or vascular ectasia in the upper dermis were also noted. All these findings had similar morphological characteristics as those observed in the males and females from the control group. Moreover, their severity was also similar and none of them showed severity higher than that observed in the control group of animals treated with the test substance at the concentration of 50%. Thus, all the findings observed on the right flanks of all the treated males and females were considered to be due to skin irritation but not to a sensitization process.
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Under the experimental conditions and according to the maximization method of Magnusson and Kligman, the test substance EDDHAS Fe 3K does not induce delayed contact hypersensitivity in guinea pigs.
- Executive summary:
The potential of Fe3KEDDHSA to induce delayed contact hypersensitivity was evaluated in guinea pigs according to the maximization method of Magnusson and Kligman (CIT, 2001; OECD TG 406). Thirty guinea pigs were allocated to two groups: a control group of five males and five females and a treated group of ten males and ten females. The concentration of 10% was determined in a preliminary study and the vehicle used was 0.9% NaCl. On day 1, three pairs of intradermal injections were performed in the interscapular region of all animals: Freund's complete adjuvant (FCA) diluted at 50% (v/v) with vehicle (both groups), test substance in vehicle (treated group) or vehicle alone (control group), test substance in a mixture FCA/0.9% NaCl 50/50 (treated group) or vehicle at the concentration of 50% (w/v) in a mixture FCA/0.9% NaCl 50/50 (control group). On day 7, the same region received a topical application of sodium lauryl sulfate in vaseline (10%, w/w) in order to induce local irritation. On day 8, the test substance (treated group) or the vehicle (control group) was applied topically to the same test site, which was then covered by an occlusive dressing for 48 hours. On day 22, all animals of the treated and control groups were challenged by a cutaneous application of the test substance to the left and right flank at concentrations of 5% and 50% (w/w), respectively. Test substance was maintained under an occlusive dressing for 24 hours. Skin reactions were evaluated approximately 24 and 48 hours after removal of the dressing. At the end of the study, animals were killed without examination of internal organs. Skin samples were taken from the challenge application sites of all the animals. A histopathological examination was performed on the preserved skin samples from the right flank (test site receiving the test substance at the maximal practicable concentration of 50% (w/w) in sterile isotonic saline solution (0.9% NaCl)).
No clinical signs and no deaths were noted during the study. After the challenge application by 5% of the test substance, a brown coloration of the skin, which could have masked a possible moderate or intense erythema, was observed at the 24-hour reading in all animals of the control and treated groups. At the 48-hour reading, a brown coloration of the skin, which could have masked a possible discrete or moderate erythema, persisted in 4/10 animals of the control group and in 11/20 animals of the treated group; dryness of the skin was also recorded in 1/20 animals of the treated group. No cutaneous reactions were observed in the other animals of both groups. On the right flank receiving the test substance at the concentration of 50% a brown coloration of the skin, which could have masked a possible moderate or intense erythema, was observed at the 24-hour reading in all animals of the control and treated groups. At the 48-hour reading, no cutaneous reactions were observed in 1/10 animals of the control group and in 2/20 animals of the treated group. A brown coloration of the skin, which could have masked a possible discrete to intense erythema, persisted in 9/10 animals of the control group and in 18/20 animals of the treated group. The microscopic examinations performed on the skin samples from the right flank receiving the test substance at the concentration of 50% revealed no evidence of a sensitization process. In conclusion, the test substance Fe3KEDDHSA does not induce delayed contact hypersensitivity in guinea pigs.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Although ECHA is providing a lot of online material in your language, part of this page is only in English. More about ECHA’s multilingual practice.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
the-echa-website-uses-cookies
find-out-more-on how-we-use-cookies